Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2012
12/20/2012US20120321651 Anti-IGE Vaccines
12/20/2012US20120321649 Peptide Vaccines for Cancers Expressing Tumor-Associated Antigens
12/20/2012US20120321643 Anti-epidermal growth factor receptor antibodies and uses thereof
12/20/2012US20120321636 Antibodies specific for sclerostin and methods for increasing bone mineralization
12/20/2012US20120321634 Estrogen receptors and methods of use
12/20/2012US20120321633 Anti-human epo receptor antibodies and methods of use
12/20/2012US20120321629 Stem cell factor inhibitor
12/20/2012US20120321628 Hepatocyte growth factor receptor antagonists and uses thereof
12/20/2012US20120321626 Multi-specific fab fusion proteins and methods of use
12/20/2012US20120321623 ILT3 Polypeptides and Uses Thereof
12/20/2012US20120321621 INHIBITION OF FcyR-MEDIATED PHAGOCYTOSIS WITH REDUCED IMMUNOGLOBULIN PREPARATIONS
12/20/2012US20120321619 Anti-c4.4a antibodies and uses thereof
12/20/2012US20120321618 Humanized anti-il 10 antibodies for the treatment of systemic lupus erythematosus (sle)
12/20/2012US20120321617 Humanized anti-il 10 antibodies for the treatment of systemic lupus erythematosus (sle)
12/20/2012US20120321614 Antibodies to c-met
12/20/2012US20120321608 Detection of mutations in a gene associated with resistance to viral infection, oas1
12/20/2012US20120321607 Factor VII Fusion Polypeptides
12/20/2012US20120321601 Increased In Vivo Circulation Time of Platelets After Storage With A Sialidase Inhibitor
12/20/2012US20120321598 Vectors and methods for long-term immune evasion to prolong tranplant viability
12/20/2012US20120321594 Methods of controlling axon or dendrite development of neuronal cells
12/20/2012US20120321593 Low oxygen culture conditions for maintaining retinal progenitor cell multipotency
12/20/2012US20120321589 Antibody Fusion Proteins with Disrupted Heparin-Binding Activity
12/20/2012US20120321573 Compositions and methods of prophylaxis for contact dermatitis
12/20/2012US20120321562 Nicotinic acid and picolinic acid derived near-infrared fluorophores
12/20/2012CA2839589A1 Methods of treating retroviral infections in felines
12/20/2012CA2806625A1 Isolated embryonic stem cells that express lineage markers and associated methods
12/19/2012EP2535404A1 Method for acquiring genetically identical gamete from lethal fish haploid-derived germ cell via germ line chimera
12/19/2012EP2535403A1 Very small embryonic-like (VSEL) stem cells and methods of isolating and using the same
12/19/2012EP2535355A2 Antibodies against CD38 for treatment of multiple myeloma
12/19/2012EP2535052A1 Method for producing nk cell enhancement-type blood product
12/19/2012EP2534242A1 Improved composition for inhibiting tumor cell proliferation
12/19/2012EP2533882A1 Zeolite membrane for cellular adhesion, growth and cultures and process for preparation thereof
12/19/2012CN1720323B 细胞培养 Cell Culture
12/19/2012CN1636229B Compositions and methods for priming monocytic dendritic cells and T cells for TH-1 response
12/19/2012CN102834524A Manufacturing method for 5-(aminomethyl)-2-chlorothiazole
12/19/2012CN102834517A Polynucleotides encoding nf-yb originating in jatropha and utilization thereof
12/19/2012CN102834516A L-threonine analysis method and l-threonine dehydrogenase
12/19/2012CN102834506A Method for producing regulatory dendritic cells
12/19/2012CN102834505A Composition and method for differentiation of human embryonic stem cells
12/19/2012CN102834503A A Continuous Culturing Device
12/19/2012CN102833997A Control of AAD dicot volunteers in monocot crops
12/19/2012CN102830053A Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm
12/19/2012CN102827880A Method for biologically synthesizing fatty alcohol from fatty acyl ACP (acyl carrier protein) reductase
12/19/2012CN102827873A Cre fusion protein functional test cell and modified Cre fusion protein
12/19/2012CN102827872A Establishment of pitressin V1 receptor stable expression cell line and its application in drug screening
12/19/2012CN102827871A Establishment of P2Y1 stable expression cell line and its application in drug screening
12/19/2012CN102827870A Establishment of ET1 stable expression cell line and its application in drug screening
12/19/2012CN102827869A Establishment of P2Y122 stable expression cell line and its application in drug screening
12/19/2012CN102827868A Establishment of pitressin V2 receptor stable expression cell line and its application in drug screening
12/19/2012CN102827867A Establishment of ET2 stable expression cell line and its application in drug screening
12/19/2012CN102827865A Plants having increased yield-related traits and a method for making the same
12/19/2012CN102827855A Nucleotide sequence of food-grade L-arabinose isomerase derived from Pediococcus pentosaceus, and application of food-grade L-arabinose isomerase
12/19/2012CN102827846A Preparation method and application of recombination coxsackie virus B3-type virus-like particles
12/19/2012CN102827815A A group of cyclodextrin glucosyltransferase, and coding gene and application thereof
12/19/2012CN102827813A Anti-human CD133 monoclonal antibody and preparation method and applications thereof
12/19/2012CN102827812A Preparation method and application of induction type neural stem cells
12/19/2012CN102827811A Human breast cancer chronic intermittent hypoxia cell line, and preparation method thereof
12/19/2012CN102827810A Non-animal-source serum-free culture medium for umbilical cord blood stem cells
12/19/2012CN102827809A Preparation method of CIK (Cytokine Induced Killer) cells with high proliferation capacity, high cytotoxic activity and high survival rate, associated CIK cells and application
12/19/2012CN102827808A Method for preparing cytokine-induced killer cells
12/19/2012CN102827807A Serum-free culture medium for mesenchymal stem cells
12/19/2012CN102827806A Method of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC)
12/19/2012CN102827805A HUVEC (human umbilical vein endothelial cell) separation, culture and subculture method
12/19/2012CN102827804A Culture medium applicable to suspension and magnification cultivation of Vero cell microcarriers and method for suspension magnification cultivation of Vero cell microcarriers
12/19/2012CN102827803A Preparation method of silkworm decellularization hemolymph liquid
12/19/2012CN102827772A Culture medium pouring method and device
12/19/2012CN102827287A Compositions and methods for diagnosing and treating cancer
12/19/2012CN102827283A Transgenic non-human animals capable of producing heterologous antibodies
12/19/2012CN102827281A Monoclonal antibody against CD2 protein and application thereof
12/19/2012CN102827280A Anti-IL-13 antibodies and use thereof
12/19/2012CN102827278A Antitumor protein P53 monoclonal antibody and application thereof
12/19/2012CN102827267A Humanized pika leptin protein, gene coding same and application thereof
12/19/2012CN102827265A Novel gene of sorting nexin (SNX) family and use thereof
12/19/2012CN102827262A OsMIOX protein and coding gene and drought defying application thereof
12/19/2012CN102329795B Cucumber violaxanthin decyclization oxidase gene promoter and application thereof
12/19/2012CN102321569B Method for constructing Kareius bicoloratus liver cell line
12/19/2012CN102286429B Sarcomatoid renal cell carcinoma cell line from people of Han nationality and preparation method thereof
12/19/2012CN102268433B Plant aging specific promoter and application thereof
12/19/2012CN102250894B Specific expression promoter for plant embryo and application thereof
12/19/2012CN102234630B Tumor engineering cells for screening reversible gene silencing drugs and application thereof
12/19/2012CN102212504B Rabbit intestinal epithelial cell line and preparation method thereof
12/19/2012CN102154347B Method for reducing expression level of PPO (polyphenol oxidase) and PSY (phytoene synthase) genes and special RNAi (RNA interference) vector thereof
12/19/2012CN102154206B Preparation method of high-purity, high-multiplication capacity and high-cytotoxin activity CIK (cytokine induced kill) cell
12/19/2012CN102093981B Method for efficiently inducing reprogramming of human body cells into pluripotent stem cells
12/19/2012CN102086438B Device and method for biological culture of cell or tissue engineering
12/19/2012CN102021175B Optimized grass carp alpha interferon encoding gene and application thereof
12/19/2012CN102002097B Mutant protein capable of being combined with nisin, and coded gene and application thereof
12/19/2012CN101948796B Method for extracting orange flesh chromoplast
12/19/2012CN101921778B Gene DvCRP1 with Cd<2+> and Cu<2+> resistance as well as coding protein and application thereof
12/19/2012CN101914534B Seedling and seed specific expression GmPLPA gene promoter for soybean and application thereof
12/19/2012CN101760452B Heterozygous cell line of embryonic stem cell and tumour cell and construction method thereof
12/19/2012CN101679968B Polypeptide capable of improving tolerance to iron deficiency in plant, and use thereof
12/19/2012CN101441222B Method for detecting Beta accompany glycinin and specific antibody and reagent kit thereof
12/19/2012CN101437540B Melanocortin receptor binding mimetibodies, compositions, methods and uses
12/19/2012CA2792025A1 Soybean cultivar ow1012932
12/18/2012US8334445 Maize variety hybrid 10967280
12/18/2012US8334438 Soybean cultivar 8919112
12/18/2012US8334436 Soybean cultivar 93454905
12/18/2012US8334430 Methods for producing hybrid seed
12/18/2012US8334374 Methods and means for obtaining modified phenotypes